May 31, 2020

A Much-Hyped COVID-19 Drug Is Almost Identical to a Black-Market Cat Cure

Posted by in category: biotech/medical

A tale of GS-441524, the remdesivir sister drug that cures coronavirus (FIP) in cats, but that Gilead refused to develop for fear it would mess up the approval process of remdesivir.

Yes, it a tale of capitalism on steroids, and the FDA on drugs. It’s the kind of thing that may well kill you and your family, but you will never know about it (unless you read about it in The Atlantic, or some obscure journal).

Cat owners are resorting to China’s underground marketplace to buy antivirals for a feline coronavirus.

Comments are closed.